| Heavy menstrual bleeding (menorrhagia) |
| Surgical bleeding |
| Capillary fragility |
| Adjunct therapy in gynecological bleeding/td> |
Tablet
This fixed-dose combination provides dual hemostatic action. Tranexamic Acid, an antifibrinolytic, prevents breakdown of blood clots, while Etamsylate enhances platelet adhesion and capillary resistance. Together, they reduce excessive bleeding in gynecological, surgical, and capillary fragility conditions.
| Speciality | Gynecology | Hematology | Surgery |
|---|---|
| Tags | Antifibrinolytic | Hemostatic Agent | Menorrhagia | Surgical Bleeding | Combination Therapy |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.